Tackling Polycystic Ovary Syndrome
January 2001
in “
Drug and therapeutics bulletin
”
polycystic ovary syndrome PCOS hirsutism male-pattern baldness acne irregular menstrual cycles obesity elevated testosterone elevated luteinising hormone insulin resistance abnormal serum lipid levels diabetes mellitus PCOS male-pattern baldness acne irregular periods obesity high testosterone high LH insulin resistance high cholesterol diabetes
TLDR The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.
The document from January 1, 2001, discusses the prevalence and characteristics of polycystic ovary syndrome (PCOS) in the UK, where up to one-third of women have polycystic ovaries, and approximately one-third of these women exhibit PCOS. PCOS is typically defined by the presence of polycystic ovaries along with symptoms such as hirsutism, male-pattern baldness, acne, irregular menstrual cycles, obesity, and elevated levels of testosterone and/or luteinising hormone. The review also highlights the associated metabolic issues with PCOS, including insulin resistance and abnormal serum lipid levels, which increase the risk of diabetes mellitus in affected women. The document aims to review the management strategies for women with PCOS.
